First-trimester or second-trimester screening, or both, for Down's syndrome.

By F. Malone, J. Canick, R. Ball, D. Nyberg, C. Comstock, R. Bukowski, R. Berkowitz, S. Gross, L. Dugoff, S. Craigo and 10 more. New England Journal of Medicine, 2005

981 citations recorded by the source corpus.

Subfields: Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/1ebba12232996c625d6a1bc0d40164d623cd447f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. K. Nicolaides

Citations in the corpus

• Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma (2008, neutral): “Methods based on ultrasound scanning and maternal serum biochemical markers (2) have proved to be useful screening tests.”
• Screening for fetal aneuploidies at 11 to 13 weeks (2011, background): “Extensive research in the last 20 years has established that the measurement of fetal NT thickness provides effective and early screening for trisomy 21 and other major aneuploidies (Snijders et al., 1998; Wald et al., 2003a; Nicolaides, 2004; Malone et al., 2005).”